Survival Analysis

"Survival Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.

Descriptor ID	D016019
MeSH Number(s)	E05.318.740.998 N05.715.360.750.795 N06.850.520.830.998
Concept/Terms	Survival Analysis Survival Analysis Analysis, Survival Analyses, Survival Survival Analyses

Below are MeSH descriptors whose meaning is more general than "Survival Analysis".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Epidemiologic Methods [E05.318]
Statistics as Topic [E05.318.740]
Survival Analysis [E05.318.740.998]
Health Care [N]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Statistics as Topic [N05.715.360.750]
Survival Analysis [N05.715.360.750.795]
Environment and Public Health [N06]
Public Health [N06.850]
Epidemiologic Methods [N06.850.520]
Statistics as Topic [N06.850.520.830]
Survival Analysis [N06.850.520.830.998]

Below are MeSH descriptors whose meaning is more specific than "Survival Analysis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Survival Analysis" by people in this website by year, and whether "Survival Analysis" was a major or minor topic of these publications.

Bar chart showing 475 publications over 31 distinct years, with a maximum of 30 publications in 2009

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	3	3
1997	0	4	4
1998	0	6	6
1999	1	9	10
2000	1	9	10
2001	0	13	13
2002	1	14	15
2003	0	14	14
2004	0	24	24
2005	0	18	18
2006	0	17	17
2007	0	21	21
2008	0	22	22
2009	1	29	30
2010	0	27	27
2011	0	17	17
2012	0	26	26
2013	1	21	22
2014	0	21	21
2015	1	23	24
2016	1	27	28
2017	1	25	26
2018	0	23	23
2019	1	19	20
2020	0	15	15
2021	1	7	8
2022	0	3	3
2023	0	2	2
2024	0	2	2
2025	0	2	2
2026	0	2	2

Below are the most recent publications written about "Survival Analysis" by people in Profiles.

Roboz GJ, Zeidan AM, Mannis GN, Montesinos P, Arnan M, Savona MR, Odenike O, McCloskey JK, Amin HV, Fathi AT, Bernal Del Castillo T, Rodr?guez-Mac?as G, Liesveld JL, Im AP, Cerny J, Gentile TC, Oganesian A, Chan D, Wan Y, Dijkstra M, Keer HN, Griffiths EA, DiNardo CD. All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia. N Engl J Med. 2026 Jun 04; 394(21):2107-2116.

View in: PubMed
Cao X, Zhou JY, Huang HY, Guo L, Huang YY, Qiu WZ, Lin ZC, Cao KJ, Mo HY, Li XM, Li ZH, Han F, He YX, Liu YM, Bai YR, Wu SX, Ke LR, Chen X, Liang CX, Luo ZY, Xia Y, Deng Y, Miao JJ, Xia WX, Liang H, Zhao C, Xiang YQ, Guo X, Lv X. Final survival analysis of induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma: a multicenter, randomized, phase 3 trial. Nat Commun. 2026 Feb 10; 17(1).

View in: PubMed
Risch Z, Bellile E, Bughrara MS, Swiecicki PL, Casper K, Malloy K, Hogikyan N, Spector M, Shuman A, Stucken C, Chinn S, Chepeha DC, Jolly S, Mierzwa M, Bradford C, Eisbruch A, Carey T, Prince M, Wolf GT, Worden FP. Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Larynx. Head Neck. 2026 05; 48(5):1311-1318.

View in: PubMed
Mohebbi E, Guthrie G, Patil S, Benjamin W, Tan M, Giurintano JP, Witek ME, Ahn PH, Taylor K, Wolf G, Fan R, Rozek LS. Postdiagnosis Smoking Cessation and Survival Outcomes of Head and Neck Cancer Patients. Head Neck. 2025 10; 47(10):2725-2734.

View in: PubMed
Pugashetti JV, Kim JS, Bose S, Adegunsoye A, Linderholm AL, Chen CH, Strek ME, Flaherty KR, Murray S, Newton CA, Alqalyoobi S, Ma SF, Mychaleckyj JC, Bowler RP, Han MK, Curtis JL, Martinez FJ, Smith JA, Noth I, Oldham JM. Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis. Am J Respir Crit Care Med. 2024 09 01; 210(5):639-647.

View in: PubMed
Zhang FG, Viswanathan S, Zhang C, Smith RV, Schiff BA, Ow TJ, Garg MK, Kabarriti R, Mehta V. Association of tumor growth rate with overall survival and recurrence among patients with laryngeal squamous cell carcinoma. Head Neck. 2025 01; 47(1):23-33.

View in: PubMed
Kim DY, Dee EC, Cheng I, Hartman RI. Advanced melanoma presentation and disease-specific survival disparities among disaggregated Asian American, Native Hawaiian, and Pacific Islander populations. J Am Acad Dermatol. 2024 03; 90(3):623-626.

View in: PubMed
Romatoski KS, Chung SH, de Geus SWL, Papageorge MV, Woods AP, Rasic G, Ng SC, Tseng JF, Sachs TE. Combined High-Volume Common Complex Cancer Operations Safeguard Long-Term Survival in a Low-Volume Individual Cancer Operation Setting. Ann Surg Oncol. 2023 Sep; 30(9):5352-5360.

View in: PubMed
Tucker SM, Zaihra T. Cytogenetic and survival analysis in 315 multiple myeloma patients; five with orbital and eight with extramedullary disease. Orbit. 2023 Dec; 42(6):603-611.

View in: PubMed
Santoni M, Molina-Cerrillo J, Massari F, Montironi R, Grande E. Re: Effect of Immunotherapy Time-of-day Infusion on Overall Survival Among Patients with Advanced Melanoma in the USA (MEMOIR): A Propensity Score-matched Analysis of a Single-centre, Longitudinal Study. Eur Urol. 2022 06; 81(6):623-624.

View in: PubMed

People

Explore

Similar Concepts

Top Journals